Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Intensive Care Med ; 37(2): 272-83, 2011 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-21107529

RESUMEN

INTRODUCTION: Early use of corticosteroids in patients affected by pandemic (H1N1)v influenza A infection, although relatively common, remains controversial. METHODS: Prospective, observational, multicenter study from 23 June 2009 through 11 February 2010, reported in the European Society of Intensive Care Medicine (ESICM) H1N1 registry. RESULTS: Two hundred twenty patients admitted to an intensive care unit (ICU) with completed outcome data were analyzed. Invasive mechanical ventilation was used in 155 (70.5%). Sixty-seven (30.5%) of the patients died in ICU and 75 (34.1%) whilst in hospital. One hundred twenty-six (57.3%) patients received corticosteroid therapy on admission to ICU. Patients who received corticosteroids were significantly older and were more likely to have coexisting asthma, chronic obstructive pulmonary disease (COPD), and chronic steroid use. These patients receiving corticosteroids had increased likelihood of developing hospital-acquired pneumonia (HAP) [26.2% versus 13.8%, p < 0.05; odds ratio (OR) 2.2, confidence interval (CI) 1.1-4.5]. Patients who received corticosteroids had significantly higher ICU mortality than patients who did not (46.0% versus 18.1%, p < 0.01; OR 3.8, CI 2.1-7.2). Cox regression analysis adjusted for severity and potential confounding factors identified that early use of corticosteroids was not significantly associated with mortality [hazard ratio (HR) 1.3, 95% CI 0.7-2.4, p = 0.4] but was still associated with an increased rate of HAP (OR 2.2, 95% CI 1.0-4.8, p < 0.05). When only patients developing acute respiratory distress syndrome (ARDS) were analyzed, similar results were observed. CONCLUSIONS: Early use of corticosteroids in patients affected by pandemic (H1N1)v influenza A infection did not result in better outcomes and was associated with increased risk of superinfections.


Asunto(s)
Corticoesteroides/uso terapéutico , Subtipo H1N1 del Virus de la Influenza A/efectos de los fármacos , Gripe Humana/tratamiento farmacológico , Unidades de Cuidados Intensivos , Pandemias , Índice de Severidad de la Enfermedad , Corticoesteroides/administración & dosificación , Corticoesteroides/efectos adversos , Adulto , Infección Hospitalaria/epidemiología , Europa (Continente)/epidemiología , Femenino , Humanos , Funciones de Verosimilitud , Masculino , Persona de Mediana Edad , Neumonía/epidemiología , Estudios Prospectivos , Sistema de Registros/estadística & datos numéricos , Análisis de Supervivencia
2.
Med Intensiva ; 34(2): 87-94, 2010 Mar.
Artículo en Español | MEDLINE | ID: mdl-20061066

RESUMEN

INTRODUCTION: Pandemic Influenza A (H1N1)v infection is the first pandemic in which intensive care units (ICU) play a fundamental role. It has spread very rapidly since the first cases were diagnosed in Mexico with the subsequent spread of the virus throughout the Southern Cone and Europe during the summer season. OBJECTIVE: This study has aimed to compare the clinical presentation and outcome among the critical patients admitted to the ICU until July 31, 2009 in Spain with some series from Latin America. MATERIAL AND METHOD: Six series of critically ill patients admitted to the ICU were considered. Clinical characteristics, complications and outcome were compared between series. RESULTS: Young patients (35-45 years) with viral pneumonia as a predominant ICU admission cause with severe respiratory failure and a high need of mechanical ventilation (60-100%) were affected. Obesity, pregnancy and chronic lung disease were risk factors associated with a worse outcome, however there was a high number of patients without comorbidities (40-50%). Mortality rate was between 25-50% and higher in the Latin America series, demonstrating the specific potential pathogenesis of the new virus. The use of antiviral treatment was delayed (between 3 and 6 days) and not generalized, with greater delay in Latin America in regards to Spain. CONCLUSIONS: These data suggest that a more aggressive treatment strategy, with earlier and easier access to the antiviral treatment might reduce the number of ICU admissions and mortality.


Asunto(s)
Brotes de Enfermedades , Subtipo H1N1 del Virus de la Influenza A , Gripe Humana/epidemiología , Adulto , Anciano , Anciano de 80 o más Años , Antivirales/uso terapéutico , Comorbilidad , Femenino , Mortalidad Hospitalaria , Humanos , Subtipo H1N1 del Virus de la Influenza A/aislamiento & purificación , Gripe Humana/complicaciones , Gripe Humana/tratamiento farmacológico , Gripe Humana/virología , Unidades de Cuidados Intensivos/estadística & datos numéricos , América Latina/epidemiología , Masculino , Persona de Mediana Edad , Oseltamivir/uso terapéutico , Embarazo , Complicaciones Infecciosas del Embarazo/epidemiología , Complicaciones Infecciosas del Embarazo/virología , Sistema de Registros , Respiración Artificial/estadística & datos numéricos , Insuficiencia Respiratoria/etiología , Insuficiencia Respiratoria/terapia , Índice de Severidad de la Enfermedad , Choque/etiología , España/epidemiología , Adulto Joven
3.
Med. intensiva ; 29(4): [1-5], 2012. tab.
Artículo en Español | LILACS | ID: biblio-906423

RESUMEN

Introducción: Los catéteres venosos centrales (CVC) plantean un alto riesgo de infección. La infección del sitio de salida (ISS-CVC) es la menos estudiada, y se desconoce su asociación con la bacteriemia asociada a catéter (BAC) y su impacto en la evolución del paciente. Objetivo: Evaluar la asociación entre ISS-CVC, BAC y mortalidad. Materiales y métodos: Estudio prospectivo, de observación. Pacientes internados en una Unidad de Terapia Intensiva médico/quirúrgica que requirieron la colocación de CVC desde el 01/06/2010 hasta el 01/04/2012. Se evaluaron datos epidemiológicos, BAC (según criterios de los CDC) y gérmenes. Se utilizaron media ± DE, mediana y rango intercuartílico, y porcentajes. Resultados: Durante este período, ingresaron 575 pacientes, el 98% requirió CVC. Datos de los pacientes: edad 41 ± 26 años, APACHE II 15 ± 7, 96% con ventilación mecánica, días de ventilación mecánica 41 (33-63), días de internación 43 (25-67). Todos los CVC con ISS fueron retirados y cultivados. Se observaron 51 ISS: 5,5/1000-días-catéter: 33% subclavia, 38% yugular, 29% femoral. Seis pacientes con ISS (12%) tuvieron BAC (0,65/1000-días-catéter): 3 subclavias, 2 yugulares, 1 femoral; 2 con halo y 8 con secreción purulenta. Tiempo de permanencia del CVC: 7,5 días (5-10). Clínica al momento de la ISS: shock 50%, fiebre 83%, SOFA 6 ± 3. El 83% de las infecciones fueron monomicrobianas: 83% por bacilos gramnegativos (2 Klebsiella, 2 Pseudomonas, 1 Serratia y 1 Acinetobacter), 17% por enterococos resistentes a vancomicina. La mortalidad fue del 50%. Conclusión: Aunque la ISS provocó una baja incidencia de BAC, la mortalidad fue alta. Al parecer, la ISS no es un factor predictivo de BAC.(AU)


Introduction: Central venous catheters (CVC) are widely used and pose a high risk of infection. There are few studies on insertion site infection (ISI-CVC), and both its association with catheter-associated bloodstream infection (CABSI) and the outcome of patients are unknown. Objective: To determine the association between ISI-CVC, the presence of CABSI and mortality. Materials and methods: Prospective observational study. All patients admitted to a medical/surgical Intensive Care Unit requiring CVC insertion from 06/01/2010 to 04/01/2012 were included. Epidemiological data, CABSI (according to CDC criteria) and microorganisms involved were evaluated. Mean ± SD, median and interquartile range, and percentages were used. Results: During the period study, 575 patients were admitted, 98% required CVC. Patient´s data: age 41 ± 26 years, APACHE II 15 ± 7, 96% on mechanical ventilation, days on mechanical ventilation: 41 (33-63), length of stay 43 (25-67) days. All CVCs with ISI were removed and cultured. Fifty one ISI were observed (5.5/1000-catheter-day). Six patients with ISI (12%) presented CABSI (0.65/1000-catheter-day): 3 in subclavian, 2 in jugular, 1 femoral; 2 with erythema and 8 with purulent secretion. CVC permanence: 7.5 day (5-10). Signs and/or symptoms at the moment of ISI: shock 50%, fever 83%, SOFA 6 ± 3. The 83% of infections were caused by one microorganism: 83% due to gram-negative bacilli (2 Klebsiella, 2 Pseudomonas, 1 Serratia, and 1 Acinetobacter), 17% due to vancomycin-resistant enterococci. The mortality rate was 50%. Conclusion: Although ISI-CVC presented a low incidence of CABSI, mortality rate was high. The ISI-CVC might have a little predictable value for CABSI.(AU)


Asunto(s)
Humanos , Bacteriemia/mortalidad , Catéteres Venosos Centrales , Infecciones , Mortalidad
4.
Med. intensiva ; 28(4)2011. tab
Artículo en Español | LILACS | ID: biblio-909184

RESUMEN

Introducción. La crisis económica argentina disminuyó la provisión adecuada de insumos en los hospitales públicos. Objetivos. 1) Evaluar si la reducción de insumos impactó en la evolución de los pacientes; 2) cuantificar la provisión de insumos durante los períodos precrisis (P1), crisis y poscrisis (P2); 3) evaluar la incidencia de infecciones durante los tres períodos. Materiales y métodos. Se evaluó la densidad de incidencia de las infecciones intrahospitalarias, la estadía en la Unidad de Terapia Intensiva y la mortalidad en los tres períodos. Los datos se presentan como media ± desviación estándar, mediana [IC 0,25-0,75] y porcentajes de acuerdo con su naturaleza. Las comparaciones se efectuaron con la prueba t o ji cuadrado. Se consideró significativo un valor p <0,05. Resultados. Durante la crisis, ingresaron pacientes con menos enfermedades preexistentes, permanecieron más días ventilados y aumentó significativamente el número de infecciones por paciente. En el período P2, se detectó una caída significativa del número de pacientes infectados con respecto a los dos períodos anteriores. En el período P1, no hubo diferencias entre la mortalidad de los infectados y de los no infectados (25% contra 33%, p = 0,31). Durante la crisis, la mortalidad de los no infectados fue menor (19% contra 40%, p = 0,0005). La provisión de insumos disminuyó durante la crisis. Las infecciones intrahospitalarias se incrementaron en forma absoluta y como densidad de incidencia durante la crisis, y descendieron en el período P2. Conclusión. Durante la crisis económica, se recortaron los gastos de insumos y aumentó el número de infecciones por paciente.(AU)


Introduction. The collapse of the Argentinean economy in 2001 caused a shortage of material resources in public hospitals. Objectives. 1) To evaluate whether the decrease of material resources affected the outcome of patients in the Intensive Care Unit; 2) to quantify the provision of resources received in the Intensive Care Unit during three periods: Pre-crisis (P1), crisis, and post-crisis (P2); 3) to evaluate the incidence of infections during the three periods. Materials and methods. We compared the incidence of nosocomial infec- incidence of nosocomial infections; Intensive Care Unit stay, and mortality in the three periods. Data are presented as media ± SD, median [IQ 0.25-0.75], and percentages according to their nature. Comparison were performed using t test and chi-squared test. A p value <.05 was considered significant. Results. During the crisis, patients with less co-morbidities were admitted, they spent more time on mechanical ventilation, and the number of infections per patient was higher. Instead, during P2, there was a significant reduction of patients infected in relation to P1 and the crisis period. In P1, mortality did not differ between infected versus non-infected patients (25% vs. 33%; p = 0.31). However, during the crisis, mortality in non-infected patients was lower (19% vs. 40%; p = 0.0005). In the crisis, provision of materials decreased. Nosocomial infections increased. The incidence of infections decreased during P2. Conclusion. Resource availability decreased significantly during the economic crisis with a marked increase in the incidence of infections in the Intensive Care Unit. (AU)


Asunto(s)
Infecciones/complicaciones , Infección Hospitalaria/economía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA